Literature DB >> 4823918

Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.

J R Givens, R N Andersen, W L Wiser, S A Fish.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4823918     DOI: 10.1210/jcem-38-5-727

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  9 in total

1.  Polycystic ovary syndrome: an enigma awaiting solution.

Authors:  M Schwartz; P R Gindoff; R Jewelewicz
Journal:  Bull N Y Acad Med       Date:  1987-03

2.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

Authors:  R S Legro; D Driscoll; J F Strauss; J Fox; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

3.  Ultrasound study of ovarian morphology in women with polycystic ovary syndrome before and during treatment with an oestrogen/progestogen preparation.

Authors:  S Venturoli; R Paradisi; E Saviotti; S Barnabé; E Porcu; R Fabbri; C Flamigni
Journal:  Arch Gynecol       Date:  1983

4.  LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome.

Authors:  F P Hohmann; J S E Laven; A G M G J Mulders; J J L Oberyé; B M J L Mannaerts; F H de Jong; B C J M Fauser
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

5.  Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome.

Authors:  Miriam A Bredella; Shilpa McManus; Madhusmita Misra
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-01       Impact factor: 3.478

6.  Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol.

Authors:  S Venturoli; R Paradisi; E Saviotti; E Porcu; R Fabbri; L F Orsini; L Bovicelli; C Flamigni
Journal:  Arch Gynecol       Date:  1985

7.  Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C.

Authors:  W Urdl
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

Review 8.  The management of patients with polycystic ovary syndrome.

Authors:  Channa N Jayasena; Stephen Franks
Journal:  Nat Rev Endocrinol       Date:  2014-07-15       Impact factor: 43.330

9.  State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

Authors:  David H Geller; Danièle Pacaud; Catherine M Gordon; Madhusmita Misra
Journal:  Int J Pediatr Endocrinol       Date:  2011-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.